NCT03499730

Brief Summary

To investigate whether midazolam has any effect on postoperative pain in outpatient surgery, the investigators will assess the impact of different midazolam doses on pain scores 24h, 7 days and 3 months after open inguinal hernia repair. The investigators hypothesize that patients being administered higher midazolam doses will refer more pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2018

Typical duration for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

September 12, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2021

Completed
Last Updated

May 18, 2021

Status Verified

May 1, 2021

Enrollment Period

1.7 years

First QC Date

April 9, 2018

Last Update Submit

May 15, 2021

Conditions

Keywords

MidazolamInguinal hernia

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain

    Pain numeric rating scale (NRS) 0-10

    24h after surgery

Secondary Outcomes (8)

  • Postoperative pain

    7 days after surgery

  • Postoperative pain

    3 months after surgery

  • Patient satisfaction

    7 days after surgery

  • Patient satisfaction

    3 months after surgery

  • Analgesic consumption

    24h after surgery

  • +3 more secondary outcomes

Interventions

The dose of preoperative midazolam is the predictor variable and will be registered as a continuous variable in a single cohort.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adult patients proposed for open inguinal hernia repair in Portuguese ambulatory surgery units, under general or spinal anesthesia.

You may qualify if:

  • \- adults proposed for open inguinal hernia repair in Portuguese ambulatory surgery units

You may not qualify if:

  • psychiatric disorders
  • alcoholism
  • illiteracy or poor understanding of the Portuguese language
  • history of chronic pain under opioids
  • recurrent surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Centro Hospitalar Baixo Vouga, EPE

Aveiro, Portugal

Location

Centro Hospitalar Universitário do Algarve

Faro, Portugal

Location

Centro Hospitalar Entre Douro e Vouga, EPE

Santa Maria da Feira, Portugal

Location

Centro Hospitalar Vila Nova de Gaia / Espinho, EPE

Vila Nova de Gaia, Portugal

Location

Related Publications (9)

  • Mantegazza P, Parenti M, Tammiso R, Vita P, Zambotti F, Zonta N. Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam. Br J Pharmacol. 1982 Apr;75(4):569-72. doi: 10.1111/j.1476-5381.1982.tb09175.x.

    PMID: 6121598BACKGROUND
  • Okulicz-Kozaryn I, Kaminska E, Luczak J, Szczawinska K, Kotlinska-Lemieszek A, Baczyk E, Mikolajczak P. The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats. J Basic Clin Physiol Pharmacol. 2000;11(2):109-25. doi: 10.1515/jbcpp.2000.11.2.109.

    PMID: 11037766BACKGROUND
  • Tatsuo MA, Salgado JV, Yokoro CM, Duarte ID, Francischi JN. Midazolam-induced hyperalgesia in rats: modulation via GABA(A) receptors at supraspinal level. Eur J Pharmacol. 1999 Apr 1;370(1):9-15. doi: 10.1016/s0014-2999(99)00096-5.

    PMID: 10323274BACKGROUND
  • Frolich MA, Zhang K, Ness TJ. Effect of sedation on pain perception. Anesthesiology. 2013 Mar;118(3):611-21. doi: 10.1097/ALN.0b013e318281592d.

    PMID: 23314164BACKGROUND
  • Kain ZN, Sevarino F, Pincus S, Alexander GM, Wang SM, Ayoub C, Kosarussavadi B. Attenuation of the preoperative stress response with midazolam: effects on postoperative outcomes. Anesthesiology. 2000 Jul;93(1):141-7. doi: 10.1097/00000542-200007000-00024.

    PMID: 10861157BACKGROUND
  • Coulthard P, Rood JP. An investigation of the effect of midazolam on the pain experience. Br J Oral Maxillofac Surg. 1992 Aug;30(4):248-51. doi: 10.1016/0266-4356(92)90268-n.

    PMID: 1510899BACKGROUND
  • Day MA, Rich MA, Thorn BE, Berbaum ML, Mangieri EA. A placebo-controlled trial of midazolam as an adjunct to morphine patient-controlled analgesia after spinal surgery. J Clin Anesth. 2014 Jun;26(4):300-8. doi: 10.1016/j.jclinane.2013.12.011. Epub 2014 Jun 2.

    PMID: 24882605BACKGROUND
  • Hasani A, Maloku H, Sallahu F, Gashi V, Ozgen SU. Preemptive analgesia with midazolam and diclofenac for hernia repair pain. Hernia. 2011 Jun;15(3):267-72. doi: 10.1007/s10029-010-0772-y. Epub 2010 Dec 28.

    PMID: 21188440BACKGROUND
  • Ong CK, Seymour RA, Tan JM. Sedation with midazolam leads to reduced pain after dental surgery. Anesth Analg. 2004 May;98(5):1289-93, table of contents. doi: 10.1213/01.ane.0000111107.18755.cc.

    PMID: 15105203BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeHernia, Inguinal

Interventions

Midazolam

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsHernia, AbdominalHerniaPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Caroline Dahlem, MD

    UPorto /CINTESIS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 17, 2018

Study Start

September 12, 2018

Primary Completion

June 5, 2020

Study Completion

March 5, 2021

Last Updated

May 18, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article might be shared with other researchers after deidentification.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 6 months following article publication.
Access Criteria
Proposals should be directed to caroline.dahlem@gmail.com. To gain access, data requestors will need to sign a data access agreement.

Locations